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Background
A bottleneck to protein pharmaceutical production can be
efficient expression of the target protein. A Pseudomonas
fluorescens-based manufacturing platform for high yield
production of non-glycosylated protein pharmaceuticals
has been developed. This platform is derived from P. fluo-
rescens biovar I strain MB101 [1]. The system's perform-
ance is due to the combination of a robust host strain, the
availability of extensive molecular biology and bioinfor-
matics tools, and a well optimized high cell density fer-
mentation process. The Systems Biology tools include a
genomics and functional genomics capability, a range of
stable plasmid vectors of various copy numbers, non-anti-
biotic-dependent plasmid maintenance [2], multiple
expression cassettes [3] and engineered host strains for
stringent control of gene expression, and the ability to
export proteins to the cell's periplasmic space.
Results
The ability to export proteins to the periplasmic space ena-
bles the formation of a precise N-terminus and formation
of disulfide bonds. Moreover, export to the periplasm can
simplify downstream processing. Multiple native P. fluo-
rescens secretion leader sequences have been evaluated for
the ability to direct heterologous proteins to the peri-
plasm. Several secretion leaders were shown to effectively
enable secretion of recombinant proteins with precise N-
terminal processing at the expected amino acid. Yields of
up to 18 g/L of secreted protein have been observed at the
20 L fermentation scale.
Conclusion
P. fluorescens is a robust expression host for high yield
expression of secreted proteins. The identification of mul-
tiple, effective secretion leaders that can direct secretion of
high levels of protein to the periplasm offers flexibility to
identify the best secretion leader for each recombinant
protein.
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